IPX066 145 (Rytary carbidopa 36.25 mg / levodopa 145 mg)
Generic Name: carbidopa/levodopa
Pill imprint IPX066 145 has been identified as Rytary carbidopa 36.25 mg / levodopa 145 mg.
Rytary is used in the treatment of parkinson's disease and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Rytary carbidopa 36.25 mg / levodopa 145 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- carbidopa/levodopa
- Imprint:
- IPX066 145
- Strength:
- carbidopa 36.25 mg / levodopa 145 mg
- Color:
- Blue
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Dopaminergic antiparkinsonism agents
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Impax Laboratories, Inc.
More about Rytary (carbidopa / levodopa)
Consumer resources
- Other brands: Sinemet, Sinemet CR, Parcopa, Duopa
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
